Faster drug discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Four MIT faculty named 2015 fellows of the National Academy of Inventors
Belcher, Bhatia, Brown, and Horvitz recognized for demonstrating a prolific spirit of innovation and invention resulting in a tangible impact on society.
MIT, Broad scientists overcome key CRISPR-Cas9 genome editing hurdle
Team re-engineers system to dramatically cut down on editing errors; improvements advance future human applications.
New system for human genome editing has potential to increase power and precision of DNA engineering
CRISPR-Cpf1 offers simpler approach to editing DNA; technology could disrupt scientific and commercial landscape.
Engineering biology
With a new DARPA contract, biological engineer Christopher Voigt aims to harness the power of living cells.
A metabolic master switch underlying human obesity
Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.
Researchers develop a new means of killing harmful bacteria
Engineered particles are capable of producing toxins that are deadly to targeted bacteria.
Seeking rare cells
Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.
Forbes hails MIT standouts in science, education, energy, technology, and health care
11 MIT affiliates and more than 30 alumni are identified as movers, makers, and game changers in their respective fields.
MIT researchers to receive awards from the Society for Neuroscience
Three neuroscientists at MIT have been selected to receive awards from the Society for Neuroscience.
Francis Collins: Scientists must engage with the world
In Compton Lecture, NIH director details the importance of reaching out to others.
Researchers engineer new mouse model to study disease
Time-saving tool takes advantage of CRISPR gene-editing technology.
Inventor creates tiny technologies for medicine; awarded $500,000 Lemelson-MIT Prize
Sangeeta Bhatia combines clinical and engineering perspectives to tackle complex health challenges.
Kellis to lead MIT team in new phase of GTEx project to elucidate basis of disease predisposition
NIH-sponsored work to characterize genetic variation in human tissues with roles in diabetes, heart disease, and cancer.